Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype polymorphisms of genes regulating nitric oxide synthesis determine long-term arteriovenous fistula patency in male hemodialysis patients.

Renal failure - 1 Jan 2016

Lee Kuo-Hua, Tsai Wen-Jung, Chen Yu-Wei, Yang Wu-Chang, Lee Chiu-Yang, Ou Shuo-Ming, Chen Yung-Tai, Chien Chih-Chiang, Lee Pui-Ching, Chung Ming-Yi, Lin Chih-Ching

Abstract excerpt

OBJECTIVES: Nitric oxide (NO) is a pivotal vasoactive substance modulating arteriovenous fistula (AVF) patency for hemodialysis (HD). Since genetic background could be the predicting factor of AVF malfunction, we aimed to investigate whether the NO-related genotype polymorphisms determine AVF survival rates. METHODS: This is a retrospective, observational, multi-center study involving eight HD units in Taiwan,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Nitric Oxide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Renal Dialysis

Share to Sex Factors

Share to Time Factors

Source

Identifiers

PMID: 26643995
DOI: 10.3109/0886022X.2015.1120096

Genes

PRMT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype polymorphisms of genes regulating nitric oxide synthesis determine long-term arteriovenous fistula patency in male hemodialysis patients.PMID 26643995Read ↗

Association of Genetic Polymorphisms of Renin-Angiotensin-Aldosterone System-Related Genes with Arterio-Venous Fistula Malfunction in Hemodialysis Patients.Semantic proximity Read ↗

The association of genotype polymorphisms with vascular access patency in hemodialysis patients.Semantic proximity Read ↗

Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.Semantic proximity Read ↗

Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study.Semantic proximity Read ↗

Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.Semantic proximity Read ↗

Thrombophilia and arteriovenous fistula survival in ESRD.Semantic proximity Read ↗

Profile of PRMT-1 gene polymorphism in hemodialysis patients with increased ADMA levels.Semantic proximity Read ↗

Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.Semantic proximity Read ↗

Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.Semantic proximity Read ↗

Distribution of dimethylarginine-dimethylaminohydrolase-II (DDAH2) gene polymorphism in hemodialysis patients.Semantic proximity Read ↗

Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.Semantic proximity Read ↗

A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.